YOSEMITE
E827934
YOSEMITE is a phase III clinical trial evaluating the efficacy and safety of faricimab in patients with diabetic macular edema.
All labels observed (1)
| Label | Occurrences |
|---|---|
| YOSEMITE canonical | 3 |
How this entity was disambiguated
This entity first appeared as the object of triple T9807336 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: YOSEMITE Context triple: [faricimab, clinicalTrial, YOSEMITE]
-
A.
Yosemite
"Yosemite" is a track by Travis Scott from his 2018 album *Astroworld*, known for its melodic flow and prominent feature from Gunna.
-
B.
Yosemite
Yosemite is a venture firm focused on funding innovative cancer research and biotechnology startups.
-
C.
Yosemite
Yosemite is a major version of Apple's macOS operating system known for introducing a flatter, modern interface and tighter integration with iOS devices.
-
D.
Yosemite National Park
Yosemite National Park is a renowned U.S. national park in the Sierra Nevada mountains, famous for its dramatic granite cliffs, waterfalls, giant sequoias, and diverse wilderness.
-
E.
Yosemite Valley
Yosemite Valley is a famous glacial valley in California’s Sierra Nevada, renowned for its towering granite cliffs, waterfalls, and central role as the scenic heart of Yosemite National Park.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: YOSEMITE Target entity description: YOSEMITE is a phase III clinical trial evaluating the efficacy and safety of faricimab in patients with diabetic macular edema.
-
A.
Yosemite
"Yosemite" is a track by Travis Scott from his 2018 album *Astroworld*, known for its melodic flow and prominent feature from Gunna.
-
B.
Yosemite
Yosemite is a venture firm focused on funding innovative cancer research and biotechnology startups.
-
C.
Yosemite
Yosemite is a major version of Apple's macOS operating system known for introducing a flatter, modern interface and tighter integration with iOS devices.
-
D.
Yosemite National Park
Yosemite National Park is a renowned U.S. national park in the Sierra Nevada mountains, famous for its dramatic granite cliffs, waterfalls, giant sequoias, and diverse wilderness.
-
E.
Yosemite Valley
Yosemite Valley is a famous glacial valley in California’s Sierra Nevada, renowned for its towering granite cliffs, waterfalls, and central role as the scenic heart of Yosemite National Park.
- F. None of above. chosen
Statements (26)
| Predicate | Object |
|---|---|
| instanceOf |
clinical trial
ⓘ
phase III clinical trial ⓘ |
| controlComparator | aflibercept ⓘ |
| drugClassEvaluated | bispecific antibody ⓘ |
| endpointCategory |
anatomical retinal outcomes
ⓘ
safety and tolerability ⓘ visual acuity outcomes ⓘ |
| evaluatesCondition | diabetic macular edema ⓘ |
| evaluatesDrug | faricimab ⓘ |
| evaluatesIndication | diabetic macular edema ⓘ |
| indicationCategory | diabetic eye disease ⓘ |
| population | adult patients with diabetic macular edema ⓘ |
| primaryObjective | evaluate efficacy of faricimab in diabetic macular edema ⓘ |
| routeOfAdministration | intravitreal injection ⓘ |
| secondaryObjective | evaluate safety of faricimab in diabetic macular edema ⓘ |
| sponsor |
Genentech
ⓘ
Roche ⓘ |
| studyDesign |
active-controlled
ⓘ
double-masked ⓘ multicenter ⓘ randomized ⓘ |
| studyType | interventional ⓘ |
| targetsPathway |
Angiopoietin-2
ⓘ
VEGF-A ⓘ
linked to:
vascular endothelial growth factor A
|
| therapeuticArea | ophthalmology ⓘ |
| trialPhase | Phase III ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: YOSEMITE Description of subject: YOSEMITE is a phase III clinical trial evaluating the efficacy and safety of faricimab in patients with diabetic macular edema.
Referenced by (3)
Full triples — surface form annotated when it differs from this entity's canonical label.